Investments in Affiliates	6 Months Ended
Investments in Affiliates	Oct. 26, 2024
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]
Investments in Affiliates	Investments in Affiliates We use the equity method to account for investments in companies if our investment provides us with the ability to exercise significant influence over operating and financial policies of the investee. Our judgment regarding the level of influence over each equity method investee includes considering key factors such as our ownership interest, representation on the board of directors, participation in policy-making decisions, other commercial arrangements, and material intercompany transactions. We evaluated the nature of our investment in affiliates of XdisplayTM ("XDC"), which is developing micro-LED mass transfer expertise and technologies, and Miortech (dba Etulipa), which is developing low power outdoor electrowetting technology. Our ownership in Miortech was 55.9 percent and in XDC was 16.4 percent as of October 26, 2024. The aggregate amount of our investments accounted for under the equity method was $257 and $1,813 as of October 26, 2024 and April 27, 2024, respectively. We determined both entities are variable interest entities, and based on management's analysis, we determined that Daktronics is not the primary beneficiary because the power criterion was not met. Therefore, as Daktronics does not have control, but is able to exercise significant influence, the investments in Miortech and XDC are accounted for under the equity method. Our proportional share of the respective affiliates' losses is included in the "Other expense and debt issuance costs write-off, net" line item in our Condensed Consolidated Statements of Operations. For the three and six months ended October 26, 2024, our share of the losses of our affiliates was $901 and $1,832 as compared to $771 and $1,461 for the three and six months ended October 28, 2023. We review our investments in affiliates for impairment indicators. There were no impairments recorded during the three and six months ended October 26, 2024 compared to an impairments of $212 and $654 during the three and six months ended October 28, 2023. We purchased services for research and development activities from our equity method investees. The total of these related party transactions for the six months ended October 26, 2024 and October 28, 2023 was $497 and $123, respectively, which is included in the "Product design and development" line item in our condensed consolidated statements of operations. A portion of our activities remain unpaid those amounts were $134 and $14 for the six months ended October 26, 2024 and October 28, 2023, respectively, which is included in the "Accounts payable" line item in our condensed consolidated balance sheets. We also have advanced our affiliates funds under convertible and promissory notes (collectively, the "Affiliate Notes"). We advanced $2,049 in the six months ended October 26, 2024 and $5,050 in fiscal year 2024 under the Affiliate Notes. The total outstanding amount of the Affiliate Notes was $16,396 and $14,241 as of October 26, 2024 and April 27, 2024, respectively. The balances of the Affiliate Notes are included in the "Investments in affiliates and other assets" line item in our condensed consolidated balance sheets. We evaluate the Affiliate Notes for impairment and credit losses. As of October 26, 2024 and April 27, 2024, no provision for losses was recorded, as management's analysis concluded the Affiliate Notes were collectable or realizable based on the rights of these instruments and related valuation of each affiliate. The Affiliate Notes balance combined with the investment in affiliates balance totaled $16,653 and $16,054 as of October 26, 2024 and April 27, 2024, respectively.